These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20387287)

  • 1. Omalizumab for childhood asthma.
    Warner JO
    Expert Rev Respir Med; 2010 Feb; 4(1):5-7. PubMed ID: 20387287
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe asthma, IgE and anti-IgE: from sceptical waiting to factual learning].
    Blanc FX
    Rev Mal Respir; 2005 Dec; 22(6 Pt 1):925-7. PubMed ID: 16220115
    [No Abstract]   [Full Text] [Related]  

  • 3. World Asthma and COPD Forum. Clinical trial results with omalizumab.
    D'Amato G
    IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594
    [No Abstract]   [Full Text] [Related]  

  • 4. Spotlight on omalizumab in allergic asthma.
    Bang LM; Plosker GL
    BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of omalizumab treatment in a baker with occupational asthma.
    Pérez Pimiento A; Bueso Fernández A; García Loria J; Rodríguez Cabreros MI; Mosquera MR; García Cubero A
    J Investig Allergol Clin Immunol; 2008; 18(6):490-1. PubMed ID: 19123449
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-IgE for asthma in inner-city children.
    Geraci C; Longo G
    N Engl J Med; 2011 Jun; 364(26):2557; author reply 2557-8. PubMed ID: 21714663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of an asthmatic patient on dialysis and awaiting transplantation with anti-IgE].
    Lafourcade MP; Martin M; Yver L
    Rev Mal Respir; 2008 Sep; 25(7):857-60. PubMed ID: 18946412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
    Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab has a place in therapy for asthma disease management.
    Pesko LJ
    J Manag Care Pharm; 2009 Apr; 15(3):284-8. PubMed ID: 19326960
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti IgE antibodies for the treatment of difficult asthma].
    Humbert M; Tonnel AB
    Rev Mal Respir; 2005 Dec; 22(6 Pt 1):983-90. PubMed ID: 16222222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination against children with severe allergies.
    Warner JO
    Pediatr Allergy Immunol; 2008 Dec; 19(8):671-2. PubMed ID: 19076563
    [No Abstract]   [Full Text] [Related]  

  • 12. Omalizumab for asthma: indications, off-label uses and future directions.
    Ben-Shoshan M
    Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):183-92. PubMed ID: 20807194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab in asthma: is the therapeutic window too small?
    Bhat KD; Calhoun WJ
    Chest; 2011 Jan; 139(1):8-10. PubMed ID: 21208873
    [No Abstract]   [Full Text] [Related]  

  • 14. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma.
    Buhl R; Solèr M; Matz J; Townley R; O'Brien J; Noga O; Champain K; Fox H; Thirlwell J; Della Cioppa G
    Eur Respir J; 2002 Jul; 20(1):73-8. PubMed ID: 12166585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of monoclonal antibodies and related agents in the treatment of respiratory disease.
    Schachter EN; Neuman T
    Drugs Today (Barc); 2009 Jul; 45(7):533-48. PubMed ID: 19834630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Omalizumab in severe asthma--case report].
    Gawlewicz-Mroczka A; Nizankowska-Mogilnicka E
    Pol Arch Med Wewn; 2006 Aug; 116(2):766-70. PubMed ID: 17424922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
    J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.
    Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H
    Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma.
    Massanari M; Kianifard F; Zeldin RK; Geba GP
    Allergy Asthma Proc; 2009; 30(5):534-9. PubMed ID: 19467177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IgE for asthma in inner-city children.
    Pavord ID; Bush A
    N Engl J Med; 2011 Jun; 364(26):2556-7; author reply 2557-8. PubMed ID: 21714664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.